PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
AC Chemotherapy (Adriamycin + Cyclophosphamide): What Patients Need to Know. AC chemotherapy has been saving lives for more than 30 years. It remains one of the standard chemotherapy regimens for breast cancer, especially when the goal is cure.
If you’ve been told you need “AC chemotherapy,” you probably have two questions:
The challenge is that AC is also among the more intensive chemotherapy regimens. Adriamycin (often called the “Red Devil”) is extremely effective against cancer cells—but it can also affect the heart, bone marrow, hair follicles, and other healthy tissues.
Fortunately, decades of research have also identified numerous evidence-based strategies that may reduce treatment toxicity without compromising the effectiveness of chemotherapy.
As both a long-term cancer survivor and cancer coach, my goal isn’t to convince you to accept or reject chemotherapy. Instead, it’s to help you understand the evidence so you can work with your oncology team to receive the greatest benefit with the least toxicity.
I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.
Before beginning AC chemotherapy, consider:
I have undergone both Adriamycin and Cytoxan. I developed long-term side effects from each. Please pay strict attention to the evidence-based non-conventional therapies shown below to reduce or eliminate your risk of side effects from these toxic chemotherapy regimens.
Scroll down the page and post a question or a comment if there’s anything you’d like to know about Folfox for Cancer..
Good luck,
David Emerson
AC Chemotherapy (Adriamycin + Cyclophosphamide)
AC combines two drugs:
| Drug | Type | Primary Action |
|---|---|---|
| Adriamycin (Doxorubicin) | Anthracycline | Damages DNA and inhibits topoisomerase II |
| Cyclophosphamide | Alkylating agent | Cross-links DNA, preventing cell division |
The drugs attack cancer cells in complementary ways, making the combination more effective than either drug alone.
AC Chemotherapy (Adriamycin + Cyclophosphamide)
AC is most commonly used for:
Less commonly, variations of doxorubicin/cyclophosphamide may be used for:
AC is frequently followed by:
This sequence is often called AC-T or ACT.
Most patients receive:
Dose-Dense AC
or
Standard AC
Treatment may be:
depending on cancer stage and biology.
Large clinical trials have shown AC reduces recurrence risk and improves survival in appropriately selected breast cancer patients.
Benefits are greatest in:
Modern regimens often build upon AC rather than replace it.
| Side Effect | How Common? | Usually Temporary? |
|---|---|---|
| Fatigue | Very common | Usually |
| Hair loss | Nearly universal | Yes |
| Nausea | Common | Yes |
| Low white blood cells | Very common | Yes |
| Anemia | Common | Usually |
| Mouth sores | Common | Yes |
| Loss of appetite | Common | Yes |
| Taste changes | Common | Yes |
| Menstrual changes | Common | Sometimes permanent |
| Infection risk | Increased | Temporary |
Unlike many chemotherapy regimens, AC has several important late toxicities.
These include:
Doxorubicin can permanently weaken heart muscle.
Risk increases with:
Rare but well documented.
Risk is generally:
Less than 1%
but increases with cumulative exposure.
Cyclophosphamide may reduce ovarian function.
Patients wishing future fertility should discuss preservation before beginning treatment.
Some patients experience:
Most improve over time.
One of the biggest misconceptions about complementary therapies is that they are “alternative medicine.”
Integrative oncology guidelines now recommend many to reduce symptoms such as anxiety, nausea, fatigue, and sleep disturbance.
Benefits include:
Goal:
150 minutes/week if tolerated.
Associated with:
May reduce:
Ice chips during selected infusions may reduce mouth sores.
Strongest evidence:
Helps reduce:
Improves:
Can reduce chemotherapy-induced hair loss in many patients receiving anthracycline-based chemotherapy.
Sleep quality strongly predicts:
Not all supplements are beneficial during AC chemotherapy.
In particular:
Always discuss supplements with your oncology team.
| Therapy | Evidence | Recommendation |
|---|---|---|
| Exercise | ⭐⭐⭐⭐⭐ | Strongly recommended |
| Mediterranean diet | ⭐⭐⭐⭐☆ | Recommended |
| Meditation | ⭐⭐⭐⭐⭐ | Strongly recommended |
| Yoga | ⭐⭐⭐⭐☆ | Recommended |
| Acupuncture | ⭐⭐⭐⭐☆ | Recommended for nausea and symptom control |
| Scalp cooling | ⭐⭐⭐⭐☆ | Recommended when available |
| Oral cryotherapy | ⭐⭐⭐⭐☆ | Recommended for mucositis prevention in appropriate settings |
| Sleep optimization | ⭐⭐⭐⭐☆ | Recommended |
| High-dose antioxidants | ⭐⭐☆☆☆ | Discuss individually with oncologist |
| Acetyl-L-carnitine | ⭐☆☆☆☆ | Not recommended for CIPN prevention |
National Cancer Institute
Adriamycin (Doxorubicin) and Cyclophosphamide Drug Information
https://www.cancer.gov/about-cancer/treatment/drugs
(Reference for mechanism, indications, and standard dosing.)
Fisher B, et al.
Twenty-year follow-up of a randomized trial comparing AC with CMF in breast cancer.
New England Journal of Medicine.
This trial established AC as a standard adjuvant regimen.
Early Breast Cancer Trialists’ Collaborative Group.
Polychemotherapy for early breast cancer.
Lancet.
One of the largest analyses showing survival benefits from anthracycline-containing chemotherapy.
Cardinale D, et al.
Anthracycline-induced cardiotoxicity. Clinical relevance and response to pharmacologic therapy.
Journal of the American College of Cardiology.
https://pubmed.ncbi.nlm.nih.gov/20117401/
Excellent review of:
Zamorano JL, et al.
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity
European Heart Journal.
https://pubmed.ncbi.nlm.nih.gov/27567406/
Morton LM, et al.
Evolving risk of therapy-related acute myeloid leukemia following chemotherapy
Blood.
https://pubmed.ncbi.nlm.nih.gov/29263008/
Smith RE.
Risk of therapy-related leukemia after breast cancer chemotherapy
Journal of Clinical Oncology.
ASCO Guideline
Fertility Preservation in Patients With Cancer
https://pubmed.ncbi.nlm.nih.gov/29620997/
Current ASCO recommendations regarding:
ASCO Guideline
Exercise, Diet and Weight Management During Cancer Treatment
Journal of Clinical Oncology (2022)
https://pubmed.ncbi.nlm.nih.gov/35576506/
One of the strongest evidence-based resources supporting exercise during chemotherapy.
Campbell KL, et al.
Exercise Guidelines for Cancer Survivors
Medicine & Science in Sports & Exercise.
Schwedhelm C, et al.
Mediterranean Diet and Cancer Risk
Nutrients.
https://pubmed.ncbi.nlm.nih.gov/30901917/
The single best paper for your supportive care section is:
Lyman GH, et al.
Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the Society for Integrative Oncology Clinical Practice Guideline
Journal of Clinical Oncology.
https://pubmed.ncbi.nlm.nih.gov/29889605/
This guideline supports:
✔ meditation
✔ yoga
✔ acupuncture
✔ music therapy
✔ stress management
✔ avoidance of acetyl-L-carnitine for CIPN prevention
✔ insufficient evidence for most dietary supplements
ASCO/SIO Guideline Update (2024)
Management of Fatigue in Adult Survivors of Cancer
https://pubmed.ncbi.nlm.nih.gov/38754041/
Supports:
Bao T, et al.
Society for Integrative Oncology–ASCO Guideline for Pain Management
https://ascopubs.org/jco/doi/10.1200/JCO.22.01357
Riley P, et al.
Oral Cryotherapy for Preventing Oral Mucositis
Cochrane Database of Systematic Reviews.
https://pubmed.ncbi.nlm.nih.gov/31386174/
One of the strongest reviews available.
Rugo HS, et al.
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy
JAMA.
https://pubmed.ncbi.nlm.nih.gov/28196239/
Janelsins MC, et al.
Cognitive Complaints Following Chemotherapy
Journal of Clinical Oncology.
https://pubmed.ncbi.nlm.nih.gov/26644535/
ASCO Guideline
Recommendations for White Blood Cell Growth Factors
Howell D, et al.
Sleep Disturbance in Adults With Cancer
Canadian Medical Association Journal.
https://pubmed.ncbi.nlm.nih.gov/26668133/
Rock CL, et al.
American Cancer Society Guideline for Diet and Physical Activity for Cancer Survivors
CA: A Cancer Journal for Clinicians.
https://pubmed.ncbi.nlm.nih.gov/31626064/
AC Chemotherapy (Adriamycin + Cyclophosphamide)